Morphic Medical

GI Dynamics is Now Morphic Medical. Learn More.

EndoBarrier in Type 2 Diabetes/Pre-Diabetes with Obstructive Sleep Apnoea Study- Preliminary Results

End-OSA trial (ISRCTN:33788132) is an NIHR sponsored research trial, to assess the extent to which patients with type 2 diabetes/pre-diabetes, obesity(BMI 30-45Kg/m²) and moderate OSA requiring CPAP are able to discontinue CPAP following EndoBarrier related weight loss.


How RESET Works

Maintenance of Efficacy After RESET

BBC News Item

DJBL for the Treatment of Type 2 Diabetes and Obesity: EASD 2022